The association of 5-HTR2A-1438A/G, COMTVal158Met, MAOA-LPR, DATVNTR and 5-HTTVNTR gene polymorphisms and antisocial personality disorder in male heroin-dependent Chinese subjects

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 36, Issue 2, 2012, Pages 282-289

  Yang, Mei ^a   Kavi, Vasish ^a   Wang, Wenfu ^b   Wu, Zhimei ^b   Hao, Wei ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Brain Hospital of Hunan Province   (China)

Author keywords

Antisocial personality disorder; Association study; Co occurring disorders; Gene; Heroin dependence; Polymorphism

Indexed keywords

5 HYDROXYTRYPTAMINE GENE; 5 HYDROXYTRYPTAMINE RECEPTOR 2A GENE; ADULT; ARTICLE; CASE CONTROL STUDY; CATECHOL O METHYLTRANSFERASE GENE; CHINESE; COMORBIDITY; CONTROLLED STUDY; DOPAMINE TRANSPORTER GENE; GENE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HEROIN DEPENDENCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOAMINE OXIDASE A GENE; PSYCHOPATHY; SINGLE NUCLEOTIDE POLYMORPHISM; VARIABLE NUMBER OF TANDEM REPEAT;

ADULT; ALLELES; ANTISOCIAL PERSONALITY DISORDER; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CATECHOL O-METHYLTRANSFERASE; DIAGNOSIS, DUAL (PSYCHIATRY); DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEROIN DEPENDENCE; HUMANS; MALE; MONOAMINE OXIDASE; POLYMORPHISM, GENETIC; RECEPTOR, SEROTONIN, 5-HT2A; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 84855339948     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2011.11.009     Document Type: Article

References (39)

1. Beitchman J.H., Mik H.M., Ehtesham S., Douglas L., Kennedy J.L. MAOA and persistent, pervasive childhood aggression. Mol Psychiatry 2004, 9:546-547.
2. Boonstra A.M., Kooij J.J., Buitelaar J.K., Oosterlaan J., Sergeant J.A., Heister J.G., et al. An exploratory study of the relationship between four candidate genes and neurocognitive performance in adult ADHD. Am J Med Genet B 2008, 147B:397-402.
3. Buckholtz J.W., Meyer-Lindenberg A. MAOA and the neurogenetic architecture of human aggression. Trends Neurosci 2008, 31:120-129.
4. Caldu X., Vendrell P., Bartres-Faz D., Clemente I., Bargallo N., Jurado M.A., et al. Impact of the COMT Val108/158 Met and DAT genotypes on prefrontal function in healthy subjects. Neuroimage 2007, 37:1437-1444.
5. Caspi A., McClay J., Moffitt T.E., Mill J., Martin J., Craig I.W., et al. Role of genotype in the cycle of violence in maltreated children. Science 2002, 297:851-854.
6. Caspi A., Langley K., Milne B., Moffitt T.E., O'Donovan M., Owen M.J., et al. A replicated molecular genetic basis for subtyping antisocial behavior in children with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 2008, 65:203-210.
7. DeYoung C.G., Getchell M., Koposov R.A., Yrigollen C.M., Haeffel G.J., af Klinteberg B., et al. Variation in the catechol-O-methyltransferase Val 158 Met polymorphism associated with conduct disorder and ADHD symptoms, among adolescent male delinquents. Psychiatr Genet 2010, 20:20-24.
8. Eley T.C., Tahir E., Angleitner A., Harriss K., McClay J., Plomin R., et al. Association analysis of MAOA and COMT with neuroticism assessed by peers. Am J Med Genet B Neuropsychiatr Genet 2003, 120B:90-96.
9. Enoch M.A., Goldman D., Barnett R., Sher L., Mazzanti C.M., Rosenthal N.E. Association between seasonal affective disorder and the 5-HT2A promoter polymorphism, -1438G/A. Mol Psychiatry 1999, 4:89-92.
10. Foley D.L., Eaves L.J., Wormley B., Silberg J.L., Maes H.H., Kuhn J., et al. Childhood adversity, monoamine oxidase a genotype, and risk for conduct disorder. Arch Gen Psychiatry 2004, 61:738-744.
11. Franklin T.R., Lohoff F.W., Wang Z., Sciortino N., Harper D., Li Y., et al. DAT genotype modulates brain and behavioral responses elicited by cigarette cues. Neuropsychopharmacology 2009, 34:717-728.
12. Fuke S., Suo S., Takahashi N., Koike H., Sasagawa N., Ishiura S. The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression. Pharmacogenomics J 2001, 1:152-156.
13. Gerra G., Garofano L., Bosari S., Pellegrini C., Zaimovic A., Moi G., et al. Analysis of monoamine oxidase A(MAO-A) promoter polymorphism in male heroin-dependent subjects: behavioural and personality correlates. J Neural Transm 2004, 111:611-621.
14. Gerra G., Garofano L., Pellegrini C., Bosari S., Zaimovic A., Moi G., et al. Allelic association of a dopamine transporter gene polymorphism with antisocial behaviour in heroin-dependent patients. Addict Biol 2005, 10:275-281.
15. Giegling I., Hartmann A.M., Möller H.J., Rujescu D. Anger- and aggression-related traits are associated with polymorphisms in the 5-HT-2A gene. J Affect Disord 2006, 96:75-81.
16. Heinz A., Goldman D., Jones D.W., Palmour R., Hommer D., Gorey J.G., et al. Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology 2000, 22:133-139.
17. Horowitz R., Kotler M., Shufman E., Aharoni S., Kremer I., Cohen H., et al. Confirmation of an excess of the high enzyme activity COMT val allele in heroin addicts in a family based haplotype relative risk study. Am J Med Genet 2000, 96:599-603.
18. Jacob C.P., Müller J., Schmidt M., Hohenberger K., Gutknecht L., Reif A., et al. Cluster B personality disorders are associated with allelic variation of monoamine oxidase A activity. Neuropsychopharmacology 2005, 30:1711-1718.
19. Li T., Liu X., Zhao J., Hu X., Ball D.M., Loh el-W, et al. Allelic association analysis of the dopamine D2, D3, 5-HT2A, and GABA(A) gamma2 receptors and serotonin transporter genes with heroin abuse in Chinese subjects. Am J Med Genet 2002, 114:329-335.
20. Li T., Chen C.K., Hu X., Ball D., Lin S.K., Chen W., et al. Association analysis of the DRD4 and COMT genes in methamphetamine abuse. Am J Med Genet B Neuropsychiatr Genet 2004, 129:120-124.
21. Lynch D.R., Mozley P.D., Sokol S., Maas N.M., Balcer L.J., Siderowf A.D. Lack of effect of polymorphisms in dopamine metabolism related genes on imaging of TRODAT-1 in striatum of asymptomatic volunteers and patients with Parkinson's disease. Mov Disord 2003, 18:804-812.
22. MacKenzie A., Quinn J. A serotonin transporter gene intron 2 polymorphic region, correlated with affective disorders, has allele-dependent differential enhancer-like properties in the mouse embryo. Proc Natl Acad Sci U S A 1999, 96:15251-15255.
23. Martinez D., Gelernter J., Abi-Dargham A., van Dyck C.H., Kegeles L., Innis R.B., et al. The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associated with significant change in dopamine transporter phenotype in humans. Neuropsychopharmacology 2001, 24:553-560.
24. McIntosh A.M., Baig B.J., Hall J., Job D., Whalley H.C., Lymer G.K., et al. Relationship of catechol-O-methyltransferase variants to brain structure and function in a population at high risk of psychosis. Biol Psychiatry 2007, 61:1127-1134.
25. Mill J., Asherson P., Browes C., D'Souza U., Craig I. Expression of the dopamine transporter gene is regulated by the 3' UTR VNTR, Evidence from brain and lymphocytes using quantitative RT-PCR. Am J Med Genet 2002, 114:975-979.
26. Miller G.M., Madras B.K. Polymorphisms in the 3'-untranslated region of human and monkey dopamine transporter genes affect reporter gene expression. Mol Psychiatry 2002, 7:44-55.
27. Moore J.H., Gilbert J.C., Tsai C.T., Chiang F.T., Holden T., Barney N., et al. A flexible computational framework for detecting, characterizing, and interpreting statistical patterns of epistasis in genetic studies of human disease susceptibility. J Theor Biol 2006, 241:252-261.
28. Myers R.L., Airey D.C., Manier D.H., Shelton R.C., Sanders-Bush E. Polymorphisms in the regulatory region of the human serotonin 5-HT2A receptor gene (HTR2A) influence gene expression. Biol Psychiatry 2007, 61:167-173.
29. Nelson R.J., Tranor B.C. Neural mechanisms of aggression. Nat Rev Neurosci 2007, 8:536-546.
30. Ni X., Chan K., Bulgin N., Sicard T., Bismil R., McMain S., et al. Association between serotonin transporter gene and borderline personality disorder. J Psychiatr Res 2006, 40:448-453.
31. Nomura M., Kusumi I., Kaneko M., Masui T., Daiguji M., Ueno T., et al. Involvement of a polymorphism in the 5-HT2A receptor gene in impulsive behavior. Psychopharmacology (Berl) 2006, 187:30-35.
32. Oosterhuis B.E., LaForge K.S., Proudnikov D., Ho A., Nielsen D.A., Gianotti R., et al. Catechol-O-methyltransferase (COMT) gene variants: possible association of the Val158Met variant with opiate addiction in Hispanic women. Am J Med Genet B Neuropsychiatr Genet 2008, 147B:793-798.
33. Oroszi G., Goldman D. Alcoholism: genes and mechanisms. Pharmacogenomics 2004, 5:1037-1048.
34. Parsons M.J., D'Souza U.M., Arranz M.J., Kerwin R.W., Makoff A.J., et al. The -1438A/G polymorphism in the 5-hydroxytryptamine type 2A receptor gene affects promoter activity. Biol Psychiatry 2004, 56:406-410.
35. Sabol S.Z., Hu S., Hamer D. A functional polymorphism in the monoamine oxidase A gene promoter. Hum Genet 1998, 103:273-279.
36. Stein M.B., Fallin M.D., Schork N.J., Gelernter J. COMT polymorphisms and anxiety-related personality traits. Neuropsychopharmacology 2005, 30:2092-2102.
37. van de Giessen E., de Win M.M., Tanck M.W., van den Brink W., Baas F., Booij J. Striatal dopamine transporter availability associated with polymorphisms in the dopamine transporter gene SLC6A3. J Nucl Med 2009, 50:45-52.
38. van Dyck C.H., Malison R.T., Jacobsen L.K., Seibyl J.P., Staley J.K., Laruelle M., et al. Increased dopamine transporter availability associated with the 9-repeat allele of the SLC6A3 gene. J Nucl Med 2005, 46:745-751.
39. Walitza S., Wewetzer C., Warnke A., Gerlach M., Geller F., Gerber G., et al. 5-HT2A promoter polymorphism -1438G/A in children and adolescents with obsessive-compulsive disorders. Mol Psychiatry 2002, 7:1054-1057.